ELIZABETH HILL: Open Payments
NPI 1992346837 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 22 payments from 12 companies in 2025. Trend: 2023 $459 · 2024 $465 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $77 |
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $53 |
| Dexcom, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Philips North America LLC | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, Dexcom G6 Transmitter, XIFAXAN, JARDIANCE, MOUNJARO, NURTEC ODT, Ambulatory Monitoring & Diagnostics Undivided, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
